We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Traditional Chinese Medicine for ST-Segment Elevation Myocardial Infarction.
- Authors
Curfman, Gregory
- Abstract
The article discusses the publication of a randomized, double-blind clinical trial involving a traditional Chinese medicine compound called Tongxinluo and its effects on preventing major adverse cardiac and cerebrovascular events (MACCEs) following ST-segment elevation myocardial infarction (STEMI). It mentions the lack of known active ingredients in Tongxinluo, presents positive results from the trial, and suggests the need for further research to identify specific beneficial components.
- Subjects
ST elevation myocardial infarction; CHINESE medicine; MYOCARDIAL infarction; ANGIOTENSIN-receptor blockers; NOBEL Prize in Physiology or Medicine
- Publication
JAMA: Journal of the American Medical Association, 2023, Vol 330, Issue 16, p1546
- ISSN
0098-7484
- Publication type
Article
- DOI
10.1001/jama.2023.19712